| Alzheimer Disease |
1 |
1 |
| Aducanumab |
0 |
0.99 |
| Food and Drug Administration (FDA) |
0 |
0.95 |
| Health Care Reform |
0 |
0.9 |
| Medicare |
0 |
0.27 |
| Social Determinants of Health |
0 |
0.24 |
| Mild Cognitive Impairment |
0 |
0.2 |
| Revenue and Practice Management |
0 |
0.8 |
| Ethics |
0 |
0.16 |
| Electrophysiology |
0 |
0.14 |
| Arrhythmia |
0 |
0.1 |
| Cognitive Impairment |
0 |
0.1 |
| Health Care Quality, Access, and Evaluation |
0 |
0.1 |
| Memory |
0 |
0.1 |
| Caregiver |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Impairment |
0 |
0.07 |
| Outpatient Clinic |
0 |
0.07 |
| Care and Maintenance of Vision |
0 |
0.06 |
| Cataract |
0 |
0.06 |
| Health Insurance |
0 |
0.05 |
| Implantable Cardioverter-Defibrillator |
0 |
0.05 |
| A-Scan Biometry |
0 |
0.03 |
| Amyloid Plaque |
0 |
0.03 |
| Attending Physician |
0 |
0.03 |
| Bioethics |
0 |
0.03 |
| Brain |
0 |
0.03 |
| California |
0 |
0.03 |
| Cognition |
0 |
0.03 |
| Defibrillator |
0 |
0.03 |
| Fellowship |
0 |
0.03 |
| Geriatrics |
0 |
0.03 |
| Health Care Economics |
0 |
0.03 |
| Health Policy |
0 |
0.03 |
| Hemorrhage |
0 |
0.03 |
| Insurance |
0 |
0.03 |
| Magnetic Resonance Imaging |
0 |
0.03 |
| Medicaid |
0 |
0.03 |
| Medical Ethics |
0 |
0.03 |
| Other Specialty |
0 |
0.03 |
| Pennsylvania |
0 |
0.03 |
| Quality of Life |
0 |
0.03 |
| Scan |
0 |
0.03 |